Report cards › Companies › Vertex Pharmaceuticals
Vertex Pharmaceuticals: Political money and lobbying (shown, not graded) records
Political money and lobbying (shown, not graded): 205 records from the U.S. Senate Office of Public Records (LDA.gov), from 2021 to 2026; 202 of them list an amount, $29,700,000 in all. Political money and lobbying (shown, not graded): 3 records from the Federal Election Commission, from 2022 to 2026; the amounts total $844,987. Outcomes as recorded: $415,487.00 to federal candidates' committees (2025-2026) (1), $231,000.00 to federal candidates' committees (2023-2024) (1), $198,500.00 to federal candidates' committees (2021-2022) (1).
Newest first; records 151 to 200 of 208. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $370,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues BUD, HCR, MED, TAX; bills named: H.R. 5376, H.R. 5801, H.R. 7506, H.R. 3259, H.R. 2617, S. 4661, H.R. 8239, S. 4659, H.R. 8295, H.R. 6833, H.R. 7667, S. 4348, S. 3799 | $370,000 · $370,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Dec 31, 2022 | Federal Election Commission | FEC: VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC) (committee C00468660; connected organization VERTEX PHARMACEUTICALS INCORPORATED) reported $198,500.00 in contributions to federal candidates' committees in the 2021-2022 cycle, reports through 2022-12-31 | $198,500 · $198,500.00 to federal candidates' committees (2021-2022) | Source record | Oct 24, 2026 | matched by name | Report an error |
| Oct 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 6833, S. 1260, H.R. 1319, H.R. 5376, H.R. 6000, S. 4348, H.R. 7667 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376, H.R. 7667, S. 4348, H.R. 6833 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 16, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 14, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $710,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues BUD, HCR, MED, TAX; bills named: H.R. 5376, H.R. 5801, H.R. 7506, H.Res. 1330, S. 4661, H.R. 8239, S. 4659, H.R. 8295, H.R. 6833, H.R. 7667, S. 4348, S. 3799 | $710,000 · $710,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376, H.R. 7667, S. 4348 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 2471, S. 1260, H.R. 1319, H.R. 5376, H.R. 6000, S. 4348, H.R. 7667 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues HCR; bills named: H.Res. 1176 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $520,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, S. 2164, H.R. 5376, H.R. 5801, H.R. 7506, S.Res. 683, H.R. 1176, S. 2599, H.R. 4356, H.R. 7667, S. 4348, S. 1260, H.R. 4521, S. 3799 | $520,000 · $520,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 18, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 17, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $520,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376, H.R. 5801, H.R. 4356, S. 1260, H.R. 4521, S. 3799 | $520,000 · $520,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 16, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 16, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 14, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 2471, S. 1260, H.R. 1319, H.R. 5376, H.R. 6000 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $630,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 5376, H.R. 3, H.R. 19, S.Res. 477, H.R. 6000, H.R. 4356 | $630,000 · $630,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 19, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 1319, S.Con.Res. 14, S. 1260, H.R. 5376 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $450,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 5376, H.R. 4356, H.R. 3, H.R. 19, H.Res. 494, H.Res. 495 | $450,000 · $450,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues HCR | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues BUD, HCR, MED, MMM, TAX; bills named: H.R. 3, H.R. 19, H.R. 5376 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: S. 1260, H.R. 1319, H.R. 3, S.Con.Res. 14 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 18, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues BUD, DEF, HCR, MED, MMM, TAX, TRD; bills named: H.R. 1319 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CAPITOL COUNSEL LLC reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues MMM, PHA, TAX | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $420,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues HCR, MMM, TAX; bills named: H.R. 3, H.R. 19, H.Res. 494, H.Res. 495 | $420,000 · $420,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2021 (2nd Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: S.Con.Res. 5, H.R. 1319, S. 1260 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2021 (1st Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: WILLIAMS AND JENSEN, PLLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2021 (1st Quarter - Report); issues BUD, DEF, HCR, MED, MMM, TAX, TRD; bills named: H.R. 1319 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2021 (1st Quarter - Report); issues HCR | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $410,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2021 (1st Quarter - Report); issues HCR, MMM, TAX | $410,000 · $410,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
CSWH is not affiliated with these agencies.